The annual cost of providing antiretroviral therapy (ART) to HIV-infected patients in Kenya averaged $224, or less than $20 per month. A paper in the Journal of the International AIDS Society provides the first published estimate of the cost of ART treatm
Researchers believe new findings will provide a new pre-clinical model to understand the early events in mucosal HIV infection and help to evaluate candidate HIV vaccines.
MHRP initiated a large, long-term cohort study at multiple African sites that will evaluate HIV prevention care and treatment services it supports through local facilities.
A novel HIV vaccine candidate developed by MHRP scientists in collaboration with Advanced BioScience laboratories will be produced for potential use in clinical studies.
